MARKET

KZIA

KZIA

Kazia Therapeuti
NASDAQ
13.38
+0.13
+0.98%
After Hours: 13.70 +0.32 +2.39% 18:25 12/04 EST
OPEN
12.93
PREV CLOSE
13.25
HIGH
16.25
LOW
12.84
VOLUME
339.67K
TURNOVER
--
52 WEEK HIGH
26.30
52 WEEK LOW
2.860
MARKET CAP
22.35M
P/E (TTM)
-1.0779
1D
5D
1M
3M
1Y
5Y
1D
Kazia Therapeutics Secures $50 Million in Private Placement to Advance Cancer Drug Development
TipRanks · 2d ago
Kazia Therapeutics Raises $50 Million in Private Placement
Reuters · 2d ago
What's Going On With Cancer Firm Kazia Therapeutics
Benzinga · 2d ago
Kazia Therapeutics trading resumes
TipRanks · 2d ago
Kazia Therapeutics trading halted, volatility trading pause
TipRanks · 2d ago
Kazia Therapeutics announces pricing of $50M private placement
TipRanks · 2d ago
Kazia Therapeutics Announces ~$50M PIPE, Selling Ordinary Shares And Pre-Funded Warrants At A Price Equivalent To $5.00 Per ADS, Each ADS Representing 500 Ordinary Shares, With Expected Net Proceeds Of ~$46.5M
Benzinga · 2d ago
BRIEF-Kazia Therapeutics Announces Pricing Of $50.0 Million Private Placement Of Equity Securities
Reuters · 2d ago
More
About KZIA
Kazia Therapeutics Limited is an oncology-focused drug development company. The Company operates in the pharmaceutical research and development business. The Company’s lead program is paxalisib, an investigational brain-penetrant inhibitor of the PI3K / Akt / mTOR pathway, which is being developed to treat multiple forms of brain cancer. It is also developing EVT801, a small-molecule inhibitor of VEGFR3, which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. It designed paxalisib to inhibit PI3K, a critical control mechanism in growth and cell division, which is activated in many forms of cancer. The Company’s drug candidates are designed to treat diseases, such as brain cancer, renal cancer, and liver cancer.

Webull offers Kazia Therapeutics Ltd (ADR) stock information, including NASDAQ: KZIA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KZIA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KZIA stock methods without spending real money on the virtual paper trading platform.